Phibro Animal Health Corporation (PAHC) To Go Ex-Dividend on September 2nd

Phibro Animal Health Corporation (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, July 28th. Investors of record on Wednesday, September 2nd will be given a dividend of 0.12 per share on Wednesday, September 23rd. This represents a c) dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, September 2nd.

Phibro Animal Health has a dividend payout ratio of 23.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Phibro Animal Health to earn $3.67 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 13.1%.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $37.67 on Monday. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of 15.44, a PEG ratio of 1.08 and a beta of 0.46. The company has a quick ratio of 1.27, a current ratio of 2.96 and a debt-to-equity ratio of 1.84. Phibro Animal Health has a 52-week low of $28.25 and a 52-week high of $60.08. The business’s 50 day moving average is $34.15 and its two-hundred day moving average is $42.22.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.14. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%.The company had revenue of $396.75 million for the quarter, compared to analysts’ expectations of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Research analysts predict that Phibro Animal Health will post 3.52 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on PAHC shares. Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 21st. Wall Street Zen lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Citigroup cut their price target on Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a report on Thursday, May 14th. Finally, Weiss Ratings lowered shares of Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, June 15th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $47.67.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.